Cell Biotech Co., Ltd. (KOSDAQ:049960)

Market Cap	83.97B
Revenue (ttm)	47.46B
Net Income (ttm)	10.11B
Shares Out	6.84M
EPS (ttm)	1,477.23
PE Ratio	8.31
Forward PE	n/a
Dividend	450.00 (3.62%)
Ex-Dividend Date	Dec 27, 2024

Volume	8,470
Average Volume	11,964
Open	12,320
Previous Close	12,440
Day's Range	12,210 - 12,530
52-Week Range	11,650 - 14,790
Beta	0.59
RSI	35.53
Earnings Date	Nov 12, 2025

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1995
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 049960

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.